German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients

Erstveröffentlichung

2017

Authors

Moebus, Volker

von Minckwitz, Gunter

Jackisch, Christian

Lueck, Hans-Joachim

Schneeweiss, Andreas

et al.

Wissenschaftlicher Artikel

Published in

Annals of Oncology ; 28 (2017), 8. - S. 1803-1810. - ISSN 0923-7534. - eISSN 1569-8041

Link to publication

https://dx.doi.org/10.1093/annonc/mdx203

Institutions

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Subject headings

[Free subject headings]: adjuvant chemotherapy breast cancer | high-risk early breast cancer | node-positive breast cancer | dose-dense chemotherapy | intense dose-dense chemotherapy | capecitabine | chemotherapy | epirubicin | cyclophosphamide | docetaxel | paclitaxel | standard | survival | efficacy | women
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record